4//SEC Filing
Verstandig Grant 4
Accession 0001209191-22-034895
CIK 0001538210other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 6:17 PM ET
Size
9.1 KB
Accession
0001209191-22-034895
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Verstandig Grant
Director
Transactions
- Purchase
Common Stock
2022-06-07$2.28/sh+26,876$61,385→ 1,105,495 total - Purchase
Common Stock
2022-06-06$2.14/sh+25,000$53,538→ 1,078,619 total - Purchase
Common Stock
2022-06-03$2.22/sh+15,000$33,374→ 1,053,619 total
Footnotes (4)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.14 to $2.45, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]Excludes 17,376 shares of common stock underlying options that are currently exercisable.
- [F3]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.06 to $2.28, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- [F4]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.13 to $2.30, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
NexImmune, Inc.
CIK 0001538210
Entity typeother
Related Parties
1- filerCIK 0001843817
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 6:17 PM ET
- Size
- 9.1 KB